ctrl K

AI Score

Unlock

Caribou Biosciences Inc. (CRBU)

AI Score

Unlock

1.08

-0.09 (-7.69%)

At close: Mar 03, 2025, 3:59 PM

1.09

0.91%

After-hours: Mar 03, 2025, 05:48 PM EST

Caribou Biosciences Income Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Revenue	34.48M	13.85M	9.6M	12.36M	5.79M
Cost of Revenue	112.08M	3.64M	984K	34.42M	23.64M
Gross Profit	-77.6M	10.21M	8.61M	-22.06M	-17.85M
Operating Income	-116.06M	-106.4M	-66.98M	-36.12M	-34.3M
Interest Income	10.7M	4.6M	148K	236K	1.05M
Pretax Income	-101.88M	-99.35M	-66.6M	-36.13M	-30.97M
Net Income	-102.07M	-99.42M	-66.92M	-34.31M	-23.43M
Selling & General & Admin	38.46M	38.02M	24.32M	14.06M	16.46M
Research & Development	112.08M	82.23M	52.26M	34.42M	23.64M
Other Expenses	n/a	7.18M	-1.35M	514K	n/a
Operating Expenses	150.54M	120.25M	76.58M	48.48M	40.09M
Interest Expense	n/a	n/a	8K	20K	4K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	150.54M	120.25M	76.58M	48.48M	40.09M
Income Tax	193K	70K	321K	-1.82M	-7.54M
Shares Outstanding (Basic)	73.81M	60.8M	60.26M	59.97M	59.97M
Shares Outstanding (Diluted)	73.81M	60.8M	60.26M	59.97M	59.97M
EPS (Basic)	-1.38	-1.64	-1.11	-0.57	-0.39
EPS (Diluted)	-1.38	-1.64	-1.11	-0.57	-0.39
EBITDA	-112.53M	-104.78M	-66M	-35.21M	-30.21M
Depreciation & Amortization	3.52M	3.64M	984K	900K	751K